Dr. Rehman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
7247 West Central
Toledo, OH 43617Phone+1 419-408-2249- Is this information wrong?
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Allergy and Immunology, 1992
- Rush University Medical CenterResidency, Pediatrics, 1987 - 1990
- Dow University of Health SciencesClass of 1983
Certifications & Licensure
- CA State Medical License 1991 - Present
- OH State Medical License 1996 - 2029
- MI State Medical License 1996 - 2025
- OH State Medical License 1996 - 2024
- WV State Medical License 1992 - 1999
- IL State Medical License 1988 - 1990
- American Board of Allergy and Immunology Allergy & Immunology
Clinical Trials
- A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary Angioedema Start of enrollment: 2012 Jan 27
- Octagam 5% Versus Comparator Post Marketing Trial Start of enrollment: 2013 May 21
- Study of Octanorm Subcutaneous IG in Patients With PID Start of enrollment: 2014 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsLong-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.Roger H Kobayashi, Jiří Litzman, Isaac Melamed, J Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, T Prescott Atkinson, Syed Rehman, Sonja Höller, Eva Tu...> ;Clinical and Experimental Immunology. 2022 Dec 15
- Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig]) in the treatment of patients with primary immu...Roger H Kobayashi, Sudhir Gupta, Isaac Melamed, J Fernando Mandujano, Ai Lan Kobayashi, Bruce Ritchie, Bob Geng, Thomas Prescott Atkinson, Syed Rehman, Eva Turpel-Kant...> ;Frontiers in Immunology. 2022 Jan 1
- 4 citationsTreatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig® [octanorm]).Roger H. Kobayashi, Jose Fernando Mandujano, Syed M. Rehman, Ai Lan Kobayashi, Bob Geng, Thomas Prescott Atkinson, Isaac Melamed, Eva Turpel-Kantor, Elisabeth Clodi, S...> ;Immunotherapy. 2021 May 6
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- ProMedica Monroe Regional HospitalMonroe, Michigan
- ProMedica Herrick HospitalTecumseh, Michigan
- ProMedica Toledo HospitalToledo, Ohio
- Mercy Health - St. Vincent Medical CenterToledo, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: